

Dr. Joan Albanell Mestres is widely recognized as one of the top oncologists in Spain, with an outstanding 28-year career in oncology. Based in Barcelona, he is the head of the breast cancer program at HM Delfos Hospital, where he leads with exceptional dedication and innovation. His clinical excellence and compassionate approach make him one of the most popular and trusted cancer specialists in Spain. Fluent in both Spanish and English, he offers his services to a diverse international patient base. Dr. Albanell Mestres earned his MBBS from the University Autónoma de Barcelona in 1989 and pursued further specialization through a residency at the renowned Vall d'Hebron Clinic. His global perspective was shaped through advanced research in New York and a PhD from the Autonomous University of Spain. Today, he also directs oncology services at Clin del Mar and the cancer research program at Del Mar. With prestigious affiliations such as GEICAM, CIBERONC, AIECA, and SEOM, Dr. Joan Albanell Mestres stands as a leading figure in Spanish oncology, consistently delivering high-quality care and advancing breast cancer research.
Dr. Joan Albanell Mestres is a leading expert in breast cancer treatment in Spain, combining clinical precision with pioneering research. His primary focus lies in advanced oncology solutions, particularly for early-stage breast cancer, metastatic conditions, and molecular therapies. At HM Delfos Hospital in Barcelona, Dr. Albanell heads the breast cancer program, where he implements evidence-based strategies to optimize patient outcomes. He is also known for directing the cancer research program at Del Mar and leading oncology services at Clin del Mar. His research has made a profound impact on the global oncology community, with over 120 peer-reviewed publications and more than 9,000 citations. He explores crucial topics such as the role of genomic platforms in chemotherapy decisions and the identification of biomarkers for bone metastases. Dr. Albanell also plays an integral role in multiple oncology networks, serving as the Research Coordinator for CIBERONC and contributing to GEICAM, AIECA, and SEOM. Recognized as a top breast cancer doctor in Spain, he continues to bridge innovation and compassionate care. Patients from around the world seek Dr. Joan Albanell Mestres for his expertise in personalized cancer treatment, advanced clinical trials, and his status as a famous oncologist at HM Delfos.